7-(Cyclopropylmethyl)-5,6-diphenyl-3-((tetrahydro-2H-pyran-4-yl)methyl)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-imine

ID: ALA5183832

Chembl Id: CHEMBL5183832

PubChem CID: 53497512

Max Phase: Preclinical

Molecular Formula: C28H30N4O

Molecular Weight: 438.58

Names and Identifiers

Canonical SMILES:  N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(CC3CC3)c2ncn1CC1CCOCC1

Standard InChI:  InChI=1S/C28H30N4O/c29-27-25-24(22-7-3-1-4-8-22)26(23-9-5-2-6-10-23)32(18-20-11-12-20)28(25)30-19-31(27)17-21-13-15-33-16-14-21/h1-10,19-21,29H,11-18H2

Standard InChI Key:  NFUAFLCBLDJZPL-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5183832

   7-(Cyclopropylmethyl)-3-(oxan-4-ylmethyl)-5,6-diphenylpyrrolo[2,3-d]pyrimidin-4-imine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 438.58

Molecular Weight (Monoisotopic): 438.2420

AlogP: 5.49

#Rotatable Bonds: 6

Polar Surface Area: 55.83

Molecular Species: BASE

HBA: 5

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 8.64

CX LogP: 4.92

CX LogD: 3.69

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.43

Np Likeness Score: -0.64

References

1. Frankowski KJ, Patnaik S, Wang C, Southall N, Dutta D, De S, Li D, Dextras C, Lin YH, Bryant-Connah M, Davis D, Wang F, Wachsmuth LM, Shah P, Williams J, Kabir M, Zhu E, Baljinnyam B, Wang A, Xu X, Norton J, Ferrer M, Titus S, Simeonov A, Zheng W, Mathews Griner LA, Jadhav A, Aubé J, Henderson MJ, Rudloff U, Schoenen FJ, Huang S, Marugan JJ..  (2022)  Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis.,  65  (12.0): [PMID:35696646] [10.1021/acs.jmedchem.2c00204]

Source

Source(1):

• Scientific Literature